Sign In to Follow Application
View All Documents & Correspondence

Cysteinyl Leukotriene Antagonists

Abstract: The present invention relates to novel cysteinyl leukotriene (specifically LTD4) antagonists, mainly to quinolin, quinoxaline or benz[c]thiazole derivatives represented by the general formula (I), or the pharmaceutically acceptable salt thereof, process of preparation thereof, and to the use of the compounds in the preparation of pharmaceutical compositions for the therapeutic treatment of disorders related to cysteinyl leukotriene, in mammals, more specially in humans.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
26 July 2011
Publication Number
05/2013
Publication Type
INA
Invention Field
PHARMACEUTICALS
Status
Email
Parent Application

Applicants

SUN PHARMA ADVANCED RESEARCH COMPANY LTD.
17/B MAHAL INDUSTRIAL ESTATE, MAHAKALI CAVES ROAD, ANDHERI (E), MUMBAI :400093, MAHARASHTRA,INDIA.

Inventors

1. MR . RATHOD RAJENDRASINH
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. NIMA COMPOUND,NEAR PRATHAM ENCLAVE,TANDALJA ROAD, BARODA-390 020,STATE OF GUJARAT,INDIA.
2. MR . BHATT , TUSHAR
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. NIMA COMPOUND,NEAR PRATHAM ENCLAVE,TANDALJA ROAD, BARODA-390 020,STATE OF GUJARAT,INDIA.
3. MR . JOSHI , KIRITKUMAR
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. NIMA COMPOUND,NEAR PRATHAM ENCLAVE,TANDALJA ROAD, BARODA-390 020,STATE OF GUJARAT,INDIA.
4. MS . DOLE , BINAKA
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. NIMA COMPOUND,NEAR PRATHAM ENCLAVE,TANDALJA ROAD, BARODA-390 020,STATE OF GUJARAT,INDIA.
5. DR.MURTY , KADIYALA V .S .N
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. NIMA COMPOUND,NEAR PRATHAM ENCLAVE,TANDALJA ROAD, BARODA-390 020,STATE OF GUJARAT,INDIA.
6. DR . THENNATI RAJAMANNAR
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. NIMA COMPOUND,NEAR PRATHAM ENCLAVE,TANDALJA ROAD, BARODA-390 020,STATE OF GUJARAT,INDIA.

Specification

Documents

Application Documents

# Name Date
1 2109-MUM-2011-ABSTRACT(26-7-2012).pdf 2018-08-10
1 2109-MUM-2011-FORM 5(26-7-2012).pdf 2018-08-10
2 2109-MUM-2011-FORM 3(26-7-2012).pdf 2018-08-10
3 2109-mum-2011-form 2.pdf 2018-08-10
3 2109-mum-2011-abstract.pdf 2018-08-10
4 2109-MUM-2011-CLAIMS(26-7-2012).pdf 2018-08-10
5 2109-mum-2011-form 2(title page).pdf 2018-08-10
5 2109-MUM-2011-CORRESPONDENCE(26-7-2012).pdf 2018-08-10
6 2109-MUM-2011-FORM 2(TITLE PAGE)-(26-7-2012).pdf 2018-08-10
6 2109-mum-2011-correspondence.pdf 2018-08-10
7 2109-MUM-2011-FORM 2(26-7-2012).pdf 2018-08-10
7 2109-MUM-2011-DESCRIPTION(COMPLETE)-(26-7-2012).pdf 2018-08-10
8 2109-mum-2011-form 1.pdf 2018-08-10
8 2109-mum-2011-description(provisional).pdf 2018-08-10
9 2109-mum-2011-form 1.pdf 2018-08-10
9 2109-mum-2011-description(provisional).pdf 2018-08-10
10 2109-MUM-2011-DESCRIPTION(COMPLETE)-(26-7-2012).pdf 2018-08-10
10 2109-MUM-2011-FORM 2(26-7-2012).pdf 2018-08-10
11 2109-MUM-2011-FORM 2(TITLE PAGE)-(26-7-2012).pdf 2018-08-10
11 2109-mum-2011-correspondence.pdf 2018-08-10
12 2109-mum-2011-form 2(title page).pdf 2018-08-10
12 2109-MUM-2011-CORRESPONDENCE(26-7-2012).pdf 2018-08-10
13 2109-MUM-2011-CLAIMS(26-7-2012).pdf 2018-08-10
14 2109-mum-2011-form 2.pdf 2018-08-10
14 2109-mum-2011-abstract.pdf 2018-08-10
15 2109-MUM-2011-FORM 3(26-7-2012).pdf 2018-08-10
16 2109-MUM-2011-FORM 5(26-7-2012).pdf 2018-08-10
16 2109-MUM-2011-ABSTRACT(26-7-2012).pdf 2018-08-10